
News|Articles|April 1, 2005
Drug Watch: Agents in late-stage development for the treatment of HIV/AIDS (April 2005) (PDF)
A review of agents in late-stage development for the treatment of HIV/AIDS (April 2005).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Myqorzo is now available for rare heart condition at a $108,400 annual price
2
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
3
Medicaid tech companies pledge $600 million to help states update systems
4
Study of antibody-Keytruda combination seeds hope for overcoming immune checkpoint inhibitor resistance, use of biomarkers
5























